Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Role of the Head Rotation Sit-Up Test in Identifying Epley-Responsive, Non-Classical Presentations of BPPV.

Medicina (Kaunas, Lithuania)·2026
Same author

Tafro syndrome: early combination therapy outcomes and prolonged thrombocytopenia-a seven-case series.

Modern rheumatology·2025
Same author

Normal Soluble Fibrin Levels Suggest a Low Probability of Pulmonary Embolism in Patients with Deep Vein Thrombosis.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2025
Same author

Correction: Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and others.

International journal of hematology·2025
Same author

Modeling ANKRD26 5'-UTR mutation-related thrombocytopenia.

Disease models & mechanisms·2025
Same author

Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and others.

International journal of hematology·2025

Related Experiment Video

Updated: Apr 2, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

18.8K

Microfluidic Shear-Based Assay for Assessing ADAMTS13 Activity Under Flow.

Noritaka Yada1

  • 1Department of General Medicine, Nara Medical University, Kashihara, Nara, Japan. n-yada@naramed-u.ac.jp.

Methods in Molecular Biology (Clifton, N.J.)
|March 31, 2026
PubMed
Summary

This study uses a microfluidic shear-based assay to investigate how ADAMTS13 (a metalloprotease) affects platelet-von Willebrand factor interactions and thrombus formation under arterial flow conditions.

Keywords:
ADAMTS13MicrofluidicsNeutrophil extracellular trapsPlateletsThrombotic thrombocytopenic purpuravon Willebrand factor

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.8K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.5K

Related Experiment Videos

Last Updated: Apr 2, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

18.8K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.8K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.5K

Area of Science:

  • Hematology
  • Biophysics
  • Biochemistry

Background:

  • Microfluidic flow chambers are crucial for thrombosis research, enabling precise evaluation of blood flow dynamics and thrombus formation.
  • ADAMTS13, a plasma metalloprotease, plays a key role in cleaving von Willebrand factor (VWF) under flow conditions.
  • Understanding ADAMTS13's function is vital for thrombosis and related bleeding disorders.

Purpose of the Study:

  • To describe a microfluidic method for investigating platelet-VWF interactions regulated by ADAMTS13.
  • To assess ADAMTS13 function in various mouse models (WT, Adamts13-/-, VWF-/-) and human blood (healthy, iTTP patients) under arterial shear stress.
  • To evaluate the therapeutic potential of DNase I, recombinant ADAMTS13, and caplacizumab within the microfluidic system.

Main Methods:

  • Utilized a microfluidic shear-based assay with whole blood from genetically modified mice and human subjects.
  • Visualized real-time platelet-neutrophil interactions using Rhodamine 6G.
  • Assessed neutrophil extracellular traps (NETs) formation and accumulation via immunofluorescence staining (CD41, SytoxGreen) after fixation.

Main Results:

  • Demonstrated the ability to visualize platelet-neutrophil interactions and NETs formation under arterial shear stress.
  • Showcased the microfluidic system's utility in evaluating the impact of ADAMTS13 deficiency and VWF deficiency on these interactions.
  • Successfully demonstrated the potential for evaluating therapeutic agents like DNase I, recombinant ADAMTS13, and caplacizumab.

Conclusions:

  • The microfluidic shear-based assay is an effective platform for studying ADAMTS13's biological function.
  • This method provides valuable insights into platelet aggregation and NETosis under physiologically relevant shear conditions.
  • The system facilitates the evaluation of novel therapeutic strategies for thrombotic disorders.